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Measurements of myocardial contrast (sonicated meglu- 
mine diatrizoate) intensity were compared with myocardial 
flow by radioactive microspheres before and after admin- 
istration of dipyridamole (OS mg/kg body weight intrave- 
nously) in 10 open chest dogs with a critical stenosis in the 
left circumflex coronary artery. Computer measurements 
of contrast time-intensity curves corrected for background 
myocardial intensity were made along 12 transmural seg- 
ments of the left ventricle at mid-papillary level and for the 
subendocardial and subepicardial half of each segment. 
After administration of dipyridamole, transmural flow 
in the control region increased significantly (p < O.OOl), 
resulting in a dipyridamole/baseline flow ratio (i.e., coro- 
nary reserve ratio) of 2.54 f 0.95. Similar changes (p < 
0.001) were seen by contrast echocardiography; the coro- 
nary reserve ratio was 2.10 f 0.60 with use of peak 
intensity and 3.48 + 1.58 with use of area under the 
time-intensity curve. In contrast, no significant changes 
were observed in myocardial flow, peak contrast intensity 
To date, coronary arteriography remains the primary 
method for determining severity of coronary artery disease 
in humans. The technique, however, is limited in the precise 
quantitation of stenosis severity (l-3) and provides little 
information about the impact of a given lesion on myocardial 
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or area under the curve in the ischemic region after 
dipyridamole. 
In the control region the ratio of subendocardial to 
subepicardial flow was similar at baseline and after dipyr- 
idamole administration as assessed by microspheres (1.08 
f 0.24 versus 1.17 f 0.25) or by area under the time- 
intensity curve (1.11 f 0.45 versus 1.11 2 0.56). In the 
ischemic region, the subendocardiahsubepicardial flow ra- 
tio decreased significantly after dipyridamole administra- 
tion as measured by microspheres (1.15 f 0.19 to 0.82 + 
0.25; p < 0.001) or by area under the curve (1.10 f 0.28 to 
0.70 f 0.47; p < 0.01). 
Thus, myocardial contrast echocardiography appears to 
be a sensitive technique with which to detect changes in 
myocardial flow induced by dipyridamole in the various 
myocardial layers of normal segments as well as of seg 
ments supplied by a critically stenotic coronary artery. 
(J Am Co11 Cardiol1989;14:1555-6S) 
perfusion (4). The physiologic significance of a coronary 
stenosis can be expressed in terms of its effect in limiting 
coronary reserve in the region supplied by the stenotic 
vessel (5-7). However, most methods used to assess coro- 
nary reserve at the time of cardiac catheterization are limited 
to measuring changes in coronary blood flow (8-18) and 
cannot properly assess regional transmural or subendocar- 
dial perfusion. 
Recently, myocardial contrast echocardiography has pro- 
vided excellent visualization of myocardial segments per- 
fused by the vessels filled with the contrast solution. The 
technique has been used to define the extent of myocardium 
at risk after experimental coronary occlusion (N-24). In 
animal models, measurements derived from the intensity 
produced by the contrast within the myocardium have 
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provided estimates of relative changes in myocardial perfu- 
sion, suggesting that the technique may have potential 
clinical applications (25,26). Studies from several laborato- 
ries (27-29) including our own (30) have shown that myocar- 
dial contrast echocardiography can be performed safely in 
humans during cardiac catheterization with the intracoro- 
nary injection of small amounts of sonicated meglumine 
diatrizoate. Furthermore, regional measurements of myocar- 
dial contrast intensity before and after the intracoronary 
administration of papaverine hydrochloride appear to differ- 
entiate regions with normal hyperemic response from those 
with an abnormal response due to the presence of an 
obstructive lesion as determined angiographically (30). 
Several measurements can be derived from the time 
course of contrast intensity within the myocardium. The 
present study was designed to further validate the accuracy 
of these measurements in an experimental model of critical 
coronary stenosis and dipyridamole-induced hyperemia. Be- 
cause the contrast effect is well visualized through the entire 
thickness of the left ventricular wall, we also attempted to 
derive measurements of contrast intensity in the inner and 
outer layers of the myocardium to assess relative changes in 
perfusion of the subendocardium and subepicardium. 
Methods 
Instrumentation. All of the experimental studies con- 
formed to the position of the American Heart Association on 
research animal use. Ten mongrel dogs, 11 to 30 kg in 
weight, were anesthetized with 30 mg/kg body weight of 
sodium pentobarbital and 0.5 mg/kg xylazine intravenously, 
intubated and ventilated with a Harvard respirator. The 
heart was exposed through a left thoracotomy and sus- 
pended in a pericardial cradle filled with warm water. The 
dogs were fitted with a left atria1 line for radioactive micro- 
sphere injection, a right carotid artery line for continuous 
blood pressure monitoring and microsphere reference blood 
sampling and a modified pigtail catheter in the aortic root for 
administration of the sonicated contrast agent. The catheter 
was secured at the site of the arteriotomy by a ligature and 
the proximal end was taped to the experiment table to 
minimize its motion. 
The proximal left circumflex and left anterior descending 
coronary arteries were dissected free from surrounding 
tissue and a Doppler flow velocity probe was placed around 
each of them. A silk tie was loosely placed around the 
circumflex coronary artery proximal to the position of the 
flow probe. This tie was used to occlude the artery tempo- 
rarily when assessing reactive hyperemia (see later). To 
produce a critical coronary stenosis, a silk thread was looped 
around the circumflex artery between the silk tie and the 
flow velocity probe. The two ends were passed through a 
plastic tube and attached to a vascular Schwartz clamp. Care 
was taken to avoid having any coronary artery branches 
between the occlusion-stenosis device and the flow velocity 
probe. Continuous recordings of arterial pressure, electro- 
cardiogram (ECG) and Doppler flow velocity signals were 
performed on an eight channel Gould-Brush strip chart 
recorder at a paper speed of 2.0 or 25 mm/s. 
A critical stenosis was created in the left circumjex 
coronary artery by stepwise tightening of the vascular clamp 
followed by a 20 s occlusion of the artery with the silk tie to 
assess reactive hyperemia. Critical coronary stenosis was 
defined as one that abolished reactive hyperemia measured 
by the Doppler probe without decreasing baseline coronary 
flow (5). 
Experimental protocol. Measurements of arterial blood 
pressure, heart rate and Doppler flow velocities were ob- 
tained simultaneously with myocardial contrast echocar- 
diography (see later) during a baseline state, a 20 s circum- 
flex artery occlusion, after the establishment of critical 
coronary stenosis before administration of dipyridamole and 
during the steady phase of the maximal dipyridamole- 
induced hyperemic effect. The dose of dipyridamole con- 
sisted of 0.5 mg/kg injected as a bolus intravenously. Maxi- 
mal hyperemia was assessed in the control region by the 
Doppler flow velocity probe and usually occurred 2 to 3 min 
after drug administration. In three dogs, contrast echocar- 
diography was also performed after release of the critical 
stenosis. 
Radioactive microspheres were injected into all animals 
at baseline and during the steady phase of the maximal 
dipyridamole effect after completion of the contrast echocar- 
diographic recording. Microspheres were also injected dur- 
ing critical stenosis before dipyridamole administration in six 
dogs and after release of the stenosis in three. Microspheres 
(15 5 3 pm [mean ? SD] in diameter; DuPont Co.) were 
obtained as 1 mCi of nuclide suspended in 10 ml of 10% 
dextran with 0.01% Tween 80 to minimize clumping. Micro- 
spheres were labeled with niobium-95, ruthenium-105, cesi- 
urn-141 or chromium-51. Before injection, the vial containing 
microspheres was vigorously agitated on a mechanical mixer 
for 2 min. Approximately 1.5 million spheres were then 
injected into the left atrium in 3 ml of normal saline solution 
over 10 to 15 s; the catheter was flushed with an additional 10 
ml of saline solution. Beginning 15 s before and continuing 
for 2 min after the end of the injection, blood was withdrawn 
from the aorta with a Harvard pump at a constant rate of 4.05 
mllmin. 
At the end of the protocol, the dogs were killed with 
potassium chloride and the heart was removed. 
Contrast echocardiography. Echocardiographic images 
of the left ventricle were obtained in short axis at the level of 
the mid-papillary muscle (Fig. 1) with the ultrasound trans- 
ducer fixed on a metal stand. A thin cellophane bag filled 
with water was used as an acoustic interface between the 
heart and the transducer. The ultrasound equipment con- 
sisted of a Hewlett-Packard series 77020 AC equipped with a 
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Figure 1. End-diastolic frames of a cross section of the 
left ventricle at mid-papillary muscle level. A, Before 
contrast injection into the aortic root; B, baseline 
contrast injection; C, contrast injection after left cir- 
cumflex artery occlusion; D, contrast injection after 
dipyridamole in the presence of a critical left circum- 
flex stenosis. The arrows indicate the “regions at risk” 
during occlusion and critical stenosis. Some contrast 
appears within the left ventricular cavity in panels C 
and D as a result of minimal aortic regurgitation during 
the injection. 
phased array 3.5 MHz transducer. The imaging plane was set 
at a maximal depth of 8 cm, which represents the distance 
closest to the focal point of this particular transducer. At this 
distance the width of the beam is 0.9 mm axial by 2 mm 
lateral by 1.8 mm azimuthal. The gain and reject settings 
were initially set for adequate myocardial visualization and 
were not changed during the remainder of the experimental 
protocol. The position of the transducer on the heart was 
marked with the aid of a silk suture on the epicardium to 
establish the proper cross-sectional plane for the analysis of 
myocardial flow by microspheres. 
Sonication of the contrast solution was done as previ- 
ously described by Keller et al. (31) utilizing a 0.5 in. 
sonomicroprobe (1.27 cm) (Heat System model W220). 
Briefly, 7 ml of meglumine diatrizoate sodium 76% was 
placed in a 10 ml plastic syringe and sonicated for approxi- 
mately 30 s until a homogenous and slightly turbid solution 
was generated. One milliliter was discarded and the remain- 
ing 6 ml was rapidly injected into the aortic root through the 
modified pigtail catheter while the echocardiographic images 
were recorded. All sonications and injections were per- 
formed manually by one of the investigators (J.C.). 
To avoid the motion interference induced by the lung 
movements in the open chest dog (32) and to maintain 
consistency of the echocardiographic slice imaged, the res- 
pirator was turned off during the injections at the end of the 
inspiratory cycle for approximately 15 s. Images were re- 
corded on 0.5 in. VHS tape starting several cardiac cycles 
before the injection of sonicated contrast medium and ending 
after the contrast effect had completely disappeared from the 
myocardium. The beginning of each injection was indicated 
on the videotape with use of a built-in microphone. 
Analysis of images. The videotaped images were played 
back on an off-line computer station (Microsonics model 
CAD 886AT) where 32 sequential end-diastolic frames were 
digitized and placed on a tine loop format starting with three 
cardiac cycles before the visual appearance of contrast in the 
myocardium. The digitized images were analyzed on an IBM 
AT computer equipped with a custom-made densitometric 
program. The endocardial and epicardial borders of the left 
ventricle at end-diastole were traced on the first frame 
excluding the papillary muscles. When tracing the epicardial 
border. care was taken to stay inside the myocardial- 
pericardial interface to prevent contamination of the myo- 
cardium by the reflections from the pericardium. The aver- 
age of the epicardial and endocardial centroids was used as 
reference to divide the ventricle into 12 equidistant radial 
segments starting at the corner of the anterior papillary 
muscle and moving counterclockwise (Fig. 2). Once this was 
done, a “template” was made that could then be placed over 
subsequent frames to maintain consistency of the regions 
examined and avoid retracing of the borders. This template 
consisted of the epicardial and endocardial contour, the 12 
equidistant segments and a computer-derived mid-wall con- 
Figure 2. Computer-derived outline of the left ventricle at mid- 
papillary level showing the 12 segments and the subdivision of each 
segment into a subenicardial and a subendocardial half. The heavier 
lines outline the ischemic (lateral-posterior) 
anterior) regions. See text for details. 
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Figure 3. Computer-derived time-intensity curves obtained at base- 
line (open circles) and after dipyridamole administration in the 
presence of a critical stenosis (closed circles). The normal control 
region is shown in the upper panel and the abnormal ischemic region 
in the lower panel. 
tour that divided each segment into a subendocardial and 
subepicardial half (Fig. 2). The program allowed operator 
interaction when needed to correct the endocardial or epi- 
cardial contours in any of the frames. 
On completion of the analysis of the 32 frames, the 
computer constructed a time-intensity curve in each of the 
segments for their respective transmural, subepicardial and 
subendocardial layers. To correct for the variability in 
regional intensities before contrast injections, the computer 
subtracted the baseline background myocardial intensity 
from each curve (25) and displayed the resultant time- 
intensity curves in different colors for easy identification. 
Smoothing of the raw data was done utilizing the least 
squares error method applied to exponential curves (Fig. 3) 
(33). The following variables were measured by the com- 
puter: 1) time to peak intensity, 2) peak intensity, 3) area 
under the time-intensity curve, 4) time to half of peak 
intensity (T Yz up) and 5) T 1/2 of the monoexponential decay 
phase of the time-intensity curve (T V2 down). 
Wall motion analysis. Measurements of radial shortening 
fraction were taken in a cardiac cycle preceding the contrast 
injection at baseline after establishment of a critical stenosis 
and at the peak of dipyridamole-induced hyperemia. The 
end-diastolic and end-systolic contours of the endocardium 
and epicardium were traced utilizing an off-line analysis 
station equipped with internal calipers (Digisonics EC 500). 
The fractional shortening (in percent) of 12 radii starting at 
the corner of the anterior papillary muscle was determined 
with a method, recently validated in our laboratory, that 
uses a floating epicardia1 centroid as reference (34). Each 
radius corresponded to a myocardial segment analyzed for 
myocardial perfusion. 
Tissue processing. The excised heart was sliced in cross 
section at the same plane where the echocardiographic 
images were obtained, as marked by the silk suture. A 1 cm 
slice (19,32) was divided into 12 equidistant segments and 
each segment into an outer (subepicardial) and inner (suben- 
docardial) layer. The segments were labeled in a counter- 
clockwise manner starting at the anterior papillary muscle. 
The papillary muscles were then excised and the resulting 24 
tissue samples were weighed. The radioactivity of the tissue 
and reference blood sample was determined with a sodium 
iodide crystal well counter. Regional myocardial blood flow 
was calculated in mllmin per gram by standard methods as 
previously described (35). The tissue processing was per- 
formed by one of the investigators without knowledge of the 
results of the contrast analysis. 
Data analysis. For each dog, the area at risk was identi- 
fied from visual inspection of the digital tine loop that was 
derived from the contrast injection obtained during transient 
occlusion of the circumflex artery and superimposed on the 
computer-derived template. This injection provided a clear 
demarcation of the area supplied by the occluded artery, 
which in all but one dog involved more than 3 of the 12 
computer-derived segments (Fig. 1). The segment corre- 
sponding to the center of this region was selected as the 
central ischemic segment. Echocardiographic- and micro- 
sphere-derived measurements from this segment and its two 
adjacent segments were averaged and used as representative 
measurements of the ischemic region. The three segments 
chosen to represent the ischemic region had the lowest 
time-intensity curves during occlusion, thus confirming the 
visual impression. In the dog with a smaller area at risk 
during occlusion, the two adjacent segments at the center of 
this area were used to derive the echocardiographic and 
microsphere data for the ischemic region. 
In a similar manner, the control region consisted of the 
average of three adjacent segments that showed normal 
contrast appearance during the transient circumflex artery 
occlusion. In most dogs the area of normal contrast appear- 
ance extended over five to seven segments. The three 
adjacent segments selected for the control region were 
usually directly opposite to the ischemic region except when 
“dropout” of echoes induced by lateral resolution occurred 
over these segments. In those instances, three other adjacent 
segments with normal contrast appearance were selected as 
the control region. 
Statistics. Linear regression analysis was used to relate 
variables derived from the contrast time-intensity curve to 
microsphere-derived blood flow measurements. Significance 
of a change in a measurement after an intervention in either 
the control or the ischemic region was assessed with the 
Student t test for paired observations. Significance level was 
established at p < 0.05. 
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Table 1. Correlation of Percent Change From Baseline of 
Different Echocardiographic Contrast Variables With Percent 
Change In Myocardial Blood Flow by Radioactive Microspheres* 
PI 
Area 
I-PI 
T % up 
T % down 
r P Intercept Slope 
0.67 0.0001 -10 0.39 
0.72 0.0001 48 0.82 
- 0.22 NS -58 -0.20 
0.34 NS -370 -2.40 
0.40 0.01 -72 0.53 
*Area = area under time-intensity curve in intensity units times seconds: 
PI = peak intensity; T 1/2 down = time to half the peak intensity of the decay 
phase, in seconds; T 1~ up = time to half the peak intensity of the contrast 
appearance phase, in seconds: t-PI = time to peak intensity, in seconds. 
Assessment of variability. Seven contrast injections se- 
lected at random from different interventions were quanti- 
tated by an independent observer and at a different time by 
the initial observer to assess the inter- and intraobserver 
variability. The variability for all five variables derived from 
the time-intensity curve was assessed in the two selected 
regions and expressed as the mean difference t SD. In a 
similar manner, seven injections of sonicated contrast me- 
dium were repeated at baseline to assess the reproducibility 
of the technique. 
Results 
Hemodynamic changes. During the injections of soni- 
cated meglumine, no wall motion abnormalities or apprecia- 
ble changes in heart rate or blood pressure were observed. 
Mean coronary Doppler flow velocity frequently showed a 
biphasic configuration with an initial decrease of 2.3 -t 4.8 
cm/s lasting for 1 or 2 s and a subsequent increase of 3.9 2 
4.1 cm/s that lasted between 4 and 70 s. 
Mean heart rate at baseline was 148 + 30 beatsimin, did 
not change significantly after placement of the critical ste- 
nosis in the circumflex artery and decreased to 136 2 35 (p < 
0.05) after administration of dipyridamole. The mean blood 
pressure was 133 + 21 mm Hg at baseline, 122 t 14 mm Hg 
(p = NS) before and 97 2 16 mm Hg after dipyridamole 
administration (p < 0.05). 
Relation of contrast variables to microsphere flow meas- 
urements (Table 1). All of the measurements derived from 
the contrast transmural time-intensity curves in the control 
and ischemic zones correlated poorly in terms of absolute 
values with myocardial blood flow measurements by micro- 
spheres (r values ranging from 0.20 to 0.42; n = 58). When 
relative changes in a contrast variable (percent change from 
baseline) were compared with changes in myocardial flow by 
microspheres (n = 38), peak intensity and area under the 
curve correlated significantly (p < 0.0001; r = 0.67 and 0.72, 
respectively), whereas the other measurements showed ei- 
ther poor or nonsignificant correlations. The correlation 
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Figure 4. Correlation between percent change in myocardial flow by 
radioactive microspheres and percent change in area under the 
time-intensity curve. Data from control regions are shown as open 
circles and data from ischemic regions as closed circles. Correlation 
coefficient = 0.72. 
between microsphere flow and area under the curve had the 
highest r value as well as a regression equation closer to the 
line of identity (Fig. 4). This measurement was selected for 
the assessment of relative perfusion of the subendocardial 
and subepicardial layers. 
Reproducibility of results (Table 2). Of the five echocar- 
diographic contrast variables derived from the time-intensity 
curve, peak intensity and area under the curve were the only 
variables with reproducible results between two observers, 
between the same observer at two different times, and 
between repeated injections. The mean differences for each 
of the three analyses were 5.3 ? 4.2,5.5 ? 3.3 and 7.5 +- 6.2 
intensity units, respectively, for peak intensity and 50 2 42, 
49 5 37 and 66 t 56 intensity units x s, respectively, for area 
under the curve. In percent, the magnitude of these differ- 
ences was in the range of 16% to 17% for peak intensity and 
24% to 27% for area under the curve. The mean differences 
observed with the other three variables were larger, a finding 
that partially explain their poor correlation with changes in 
myocardial blood flow by microspheres. 
Myocardial blood flow changes (Table 3). At baseline, 
transmural flow by microspheres did not differ between the 
control and the ischemic area (1.56 2 0.64 versus 1.59 ? 0.84 
mlimin per g). Likewise, after the creation of a critical 
stenosis in six dogs, flow was similar in the two areas. After 
dipyridamole administration and in the presence of a critical 
coronary stenosis, flow increased in the control region to 
3.60 2 1.38 ml/min per g (p < 0.001) and remained un- 
changed in the ischemic region. Both peak intensity and area 
under the curve did not differ between the control and 
ischemic region at baseline nor after creation of a critical 
stenosis. After dipyridamole administration, both variables 
increased significantly in the normal region (p < 0.001) but 
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Table 2. Assessment of Variability of Measurements of Echocardiographic Contrast Variables 
Interobserver Variability (n = 14) 
Variable Observer 1 Observer 2 Mean Difference 
PI 
Area 
t-PI 
T v2 up 
T v2 down 
Variable 
31 * 15 33 + 13 5.3 + 4.2 
206 f. 130 192 k 105 50 + 42 
3.1 + 3.2 2.1 + 1.1 1.8 + 2.5 
2.3 + 4.2 1.4 + 2.5 1.7 ? 3.5 
6.1 + 3.9 4.3 * 1.7 3.0 + 2.0 
Intraobserver Variability (n = 14) 
Observer 1 Observer 2 Mean Difference 
PI 
Area 
t-PI 
T % up 
T M down 
Variable 
PI 
Area 
t-PI 
T 1/2 up 
T % down 
31 + I5 
206 ? 130 
3.1 + 3.2 
2.3 ? 4.2 
6.1 + 3.9 
Contrast 
Injection I 
45 + 22 
237 & 149 
2.2 + 0.59 
0.46 t 0.21 
3.3 + 0.81 
34 + 14 5.5 r 3.28 
208 f 122 49 2 31 
3.1 + 1.5 1.5 k 1.9 
1.1 + 1.2 1.6 + 3.5 
5.3 f 2.1 4.0 + 3.5 
Reproducibility (n = 14) 
Contrast 
Injection 2 Mean Difference 
50 * 25 1.5 t 6.2 
255 -+ 179 66 * 56 
2.3 ? 0.83 0.72 ir 0.62 
0.57 2 0.68 0.25 2 0.47 
3.5 + 1.6 1.3 f 0.88 
Inj = contrast injection; other abbreviations as in Table 1. 
remained unchanged (p = NS) in the ischemic zone. In the 
normal region, the coronary reserve ratio (i.e., dipyridam- 
oleibaseline) was 2.54 ? 0.95 by microspheres, 2.10 rf: 0.60 
by peak intensity and 3.48 t 1.58 by area under the curve. 
Mean Jlow velocity by Doppler probe was similar in the 
control and ischemic regions at baseline and with critical 
stenosis. After dipyridamole administration, mean velocity 
increased 2.00 ? 0.9 times in the normal region, from 32 + 12 
to 65 ? 27 cm/s (p < O.OOl), and remained unchanged in the 
ischemic region. Changes in Doppler flow velocity corre- 
lated significantly with changes in microsphere-derived myo- 
cardial flow (r = 0.74; p < 0.001). 
Subenducardial and subepicardial Row changes (Table 4). 
After dipyridamole administration, flow increased signifi- 
cantly in the subendocardial and subepicardial layers of the 
control area as measured by microspheres. The ratio of 
subendocardial to subepicardial flow (i.e., endocardiall 
epicardial ratio), however, remained unchanged from base- 
line (1.08 ? 0.24) to the dipyridamole study (1.17 ? 0.25). In 
contrast, in the ischemic region, no significant change oc- 
curred after dipyridamole administration in either subendo- 
cardial or subepicardial flow but the endocardiaYepicardia1 
ratio decreased significantly from 1.15 rt 0.19 to 0.82 + 0.25 
(p < 0.001). 
After dipyridamole administration, the area under the 
curve in the subendocardial and subepicardial halves of 
the control region increased significantly. The endocardiau 
epicardial ratio, however, remained unchanged (baseline, 
1.11 + 0.45; dipyridamole, 1.11 ? 0.56). In the ischemic 
region, no significant change occurred after dipyridamole 
Table 3. Summary for Results of Blood Flow Changes in Transmural Segments in 10 Dogs* 
Control Region 
Dipyridamole- 
Baseline Stenosis Stenosis Baseline 
(n = 10) (n = 10) (n = 10) (n = 10) 
Microspheres 1.56 + 0.64 1.49 ? 0.40 3.60 + 1.38t 1.59 * 0.84 
(ml/min/per g) (n = 6) 
Peak intensity (NJ) 39 5 16 36 f 15 74 2 28t 41 + 18.6 
Area (IU x s) 213 + 128 209 + 144 614 ? 3lOt 216 -+ 123 
DFV (cm/s) 32 ? 12 32 ? 14 65 + 2lt 292 13 
Ischemic Region 
Stenosis 
(n = 10) 
1.24 ” 0.23 
(n = 6) 
39 + 16 
224 t 141 
21 2 10 
Dipyridamole- 
Stenosis 
(n = 10) 
1.26 + 0.93 
44 _’ 31 
326 r 350 
19 + 15 
*p < 0.001 versus baseline. Area = area under time-intensity curve; DFV = Doppler flow velocity; IU = intensity units. 
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Table 4. Subendocardial and Subepicardial Blood Flow Assessment by Myocardial Contrast Echocardiography and 
Radioactive Microspheres* 
Baseline 
Control Region 
Stenosis 
Dipyridamole- 
Stenosis Baseline 
Ischemic Region 
Stenosis 
Dipyridamole- 
Stenosis 
Microspheres 
Endo 
Epi 
EndolEpi 
Contrast 
Endo 
Epi 
EndoiEpi 
(n = 10) 
1.58 ? 0.62 
1.55 t 0.72 
1.08 f 0.24 
(n = 10) 
224 t 118 
229 ? 146 
1.11 2 0.45 
(n = 6) 
2.21 + 1.34 
1.37 + 0.39 
1.18 k 0.20 
(n = IO) 
244 -+ 212 
218 + 135 
1.07 2 0.40 
(n = IO) 
3.85 ir 1.55i: 
3.35 + 1.3lf 
1.17 t 0.25 
(n = IO) 
623 ? 329+ 
612 + 331$ 
1.11 + 0.56 
(n = 10) 
1.69 + 0.84 
1.50 2 0.04 
1.15 t 0.19 
(n = IO) 
235 + 118 
229 t 129 
1.10 2 0.28 
(n = 6) 
1.60 t 0.59 
1.20 t 0.22 
1.08 lr 0.38 
(n = IO) 
243 + 143 
232 2 153 
1.17 + 0.55 
(n = 10) 
1.18 2 1.02 
1.29 2 0.78 
0.82 + 0.25t 
(n = IO) 
255 k 258 
410 t 290 
0.70 r 0.47t 
*Endo = subendocardial; Epi = subepicardial; tp < 0.01 versus baseline. $p < 0.001 versus baseline. 
administration in the area under the curve of the subendocar- 
dial and subepicardial half. The endocardiallepicardial ratio 
of these areas, however, decreased significantly from 1.10 2 
0.28 to 0.70 + 0.47 (p < 0.01). 
Regional wall motion. Before dipyridamole administra- 
tion and in the presence of a critical stenosis, radial short- 
ening fraction was similar to baseline in both the control 
(29 ? 13% versus 27 5 10%) and in the ischemic region (21 
-t 10% versus 27 + 15%). After dipyridamole administration, 
radial shortening fraction increased to 34 ? 10.5% in the 
control region (p < 0.05) and decreased to 2 ? 26% in the 
ischemic region (p < 0.01). 
Discussion 
Quantitation of myocardial blood flow. The myocardial 
contrast effect produced by the rapid injection of sonicated 
meglumine diatrizoate allows visualization of myocardial 
segments perfused by the corresponding coronary arteries. 
The time-intensity curve derived from sequential measure- 
ments of video intensity, corrected for myocardial back- 
ground, resembles an indicator-dilution curve in that it 
has an ascending limb, a peak and a descending or wash- 
out phase. However, the lack of knowledge of the amount 
of microbubbles injected, the absence of an adequate 
mixing chamber and the inability to determine the absolute 
concentration of microbubbles from the contrast intensity 
in the myocardium preclude exact computation of myo- 
cardial flow. It is, therefore, not surprising that in the 
present investigation we did not find a good correlation 
between any of the measurements derived from the time- 
intensity curves and absolute myocardial flow by micro- 
spheres. Similar results were recently reported by Keller 
et al. (32). 
Assessment of relative changes in myocardial flow. De- 
spite these limitations, previous studies have shown a rela- 
tion between changes in the time-intensity curve and 
changes in myocardial blood flow. Kemper et al. (25) and 
Gage et al. (36), using a dog model of coronary occlusion and 
of reactive hyperemia, respectively, found that changes in 
peak intensity paralleled changes in myocardial perfusion as 
assessed by radioactive microspheres. Other authors (37,38) 
found that time-derived measurements correlated favorably 
with coronary blood flow changes determined by electro- 
magnetic flowmeters in a dog model in which coronary flow 
was altered mechanically and pharmacologically. 
We selected a model of critical coronary stenosis and 
dipyridamole-induced hyperemia to simulate the clinical 
setting. Preliminary findings in a pilot study by our labora- 
tory suggested that changes in peak contrast intensity could 
be used to measure regional coronary reserve (26). In the 
present investigation we found that peak intensity and area 
under the time-intensity curve differentiated the normal 
twofold to threefold increase in flow in the control region 
from the no-change in flow observed in the ischemic region. 
The two variables followed directionally and in magnitude 
the changes in myocardial perfusion detected in these 
areas by radioactive microspheres. However, the results 
were slightly better with area under the curve in terms of 
correlation coefficient and slope of the regression equation. 
In contrast, time-derived measurements such as time to peak 
intensity were unreliable and did not follow consistently the 
changes in myocardial flow. The wide range of variability 
observed with these time measurements may explain in part 
their poor performance as indexes of myocardial perfusion. 
Keller et al. (32) likewise recently found that area under the 
time-intensity curve was better than the other measurements 
in distinguishing normal from abnormal coronary reserve; 
their model was similar to ours but the left anterior descend- 
ing artery instead of the left circumflex artery was used for 
placement of the critical stenosis, and the microbubbles 
were injected directly into the coronary arteries. Further- 
more, they found similar results in a small group of patients 
with significant single vessel coronary artery disease. 
The experimental design used in this investigation may 
have favored peak intensity and area under the curve rather 
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than time-derived measurements as variables of myocardial 
perfusion. With the method used in this study, sonication of 
meglumine diatrizoate produces microbubbles ranging in 
size from 5 to 12 pm (31,39,40). These bubbles are small 
enough to pass through the microvasculature without de- 
monstrable deleterious effects but many of them are larger 
than the average red blood cell and potentially subject to 
partial trapping or slowing down by capillaries, which may 
explain the poor results observed with T 1/2 of the decay 
phase, because this variable depends on an uninterrupted 
“washout” of the microbubbles from the microvasculature. 
Administration of dipyridamole results in profound arteriolar 
dilation that increases blood flow to the normally perfused 
myocardium (7). This increase in flow, combined with the 
potential for partial trapping of larger bubbles, may increase 
the volume of bubbles (and consequently the contrast inten- 
sity) present in the myocardium at a given time, thus 
enhancing the differences in intensity between the control 
and ischemic regions. 
Although peak intensity and area under the curve are 
sensitive enough to differentiate normal coronary reserve 
from lack of reserve produced by a critical coronary steno- 
sis, their sensitivity to modest changes in myocardial flow in 
regions supplied by a noncritical stenosis remains to be 
established. Nevertheless, in a recent human study from our 
laboratory (30), a diminished response in peak intensity 
(Cl0 U increase) after intracoronary injection of papaverine 
was found to be 80% sensitive and 92% specific in detecting 
segments supplied by arteries with ~50% diameter stenosis, 
suggesting that the technique might be sensitive to less 
severe levels of stenosis. 
Magnitude of coronary reserve. The increase in myocar- 
dial flow observed in the normal region (2.54 2 0.95) after 
dipyridamole administration, was smaller than that reported 
by other investigators (7,8,41,42). Recently, Kirkeeide et al. 
(43) demonstrated that afterload plays an important role in 
modifying the hyperemic response of normal coronary arter- 
ies. In our study, mean systemic blood pressure dropped 
significantly, an average of 25 mm Hg after the injection of 
dipyridamole, and this may have limited the vasodilator 
reserve of the coronary arteries. Because dipyridamole was 
injected as a bolus, it is possible that the hemodynamic 
effects could have been greater than when a 4 min infusion is 
used. However, both techniques of administration have been 
shown to produce similar increases in coronary blood flow 
(7). Although the decrease in blood pressure may have 
limited the coronary reserve, the assessment of myocardial 
perfusion by contrast study and by microspheres was made 
at a time when the increase in coronary flow velocity had 
reached a plateau phase so that the results of the two 
techniques could be properly compared. 
Assessment of subendocardiatisubepicardial flow relation. 
In addition to evaluating average transmural flow we ex- 
plored the possibility of assessing the transmural distribution 
of myocardial perfusion with contrast echocardiography. 
Dipyridamole administration resulted in a significant reduc- 
tion in the endocardiallepicardial flow ratio measured by 
microspheres in the ischemic region. Furthermore, this was 
associated with the development of hypokinesia in these 
regions as detected by radial shortening fraction. A similar 
change in endocardiaVepicardia1 ratio was observed by con- 
trast echocardiography with use of the area under the 
time-intensity curves of the subendocardial and subepicar- 
dial layers. No change in the ratio was observed by either 
technique in the control region. The reduction in the en- 
docardiallepicardial ratio detected by microspheres and by 
contrast echocardiography in the ischemic region was simi- 
lar in magnitude to that found by Gross and Warltier (44) 
using radioactive microspheres in a similar model of critical 
coronary stenosis. Although these findings suggest a redis- 
tribution of flow toward the control region and away from 
the subendocardium of the ischemic region after dipyridam- 
ole administration, we cannot state with confidence that the 
changes were due to a true “steal phenomenon,” because 
we did not control for changes in heart rate and blood 
pressure (45). 
The ability to follow up changes in blood jlow in the 
different myocardial layers represents an obvious advantage 
of contrast echocardiography over other nontomographic 
methods of evaluating coronary flow. Using this technique, 
Kemper et al. (46) recently demonstrated progressive in- 
creases in myocardial contrast intensity over time in the 
ischemic area after a complete coronary occlusion. This 
increase, probably resulting from collateral flow, was more 
apparent in the subepicardium, again suggesting that con- 
trast echocardiography can differentiate among flow changes 
in the different layers of the myocardium. A recent report in 
humans by Lim et al. (47) has suggested a decrease in 
subendocardial compared with subepicardial contrast inten- 
sity during rapid atria1 pacing in segments supplied by a 
stenotic coronary artery. 
Limitations of the technique. Multiple factors can affect 
the reflected ultrasound energy when evaluating a myo- 
cardial “contrast effect.” As discussed earlier, the absolute 
size and number of microbubbles injected (48) and their 
volume of distribution (49) are important factors. In addi- 
tion, gain and reject settings, depth of penetration and 
degree of attenuation, angle of incidence, axial and lateral 
resolution and gray scale compression play important roles 
in the quality of contrast intensity as well as in spatial and 
temporal heterogeneity of the intensity observed throughout 
the myocardial segments (50-53). This limits the visual 
(qualitative) interpretation of contrast injections because the 
difference in brightness observed between regions is affected 
by all of these factors in addition to myocardial flow. 
Quantitative techniques with background subtraction are 
thus necessary to evaluate the relation of contrast intensity 
to flow. 
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Gray scale compression is of particular importance when 
attempting to use pixel intensity as a measure of the number 
of microbubbles. Current ultrasound instruments lack an 
expanded linear dynamic range for processing the amplitude 
of reflected echoes. The compression techniques utilized are 
aimed at creating an attractive image rather than quantitating 
the reflected ultrasound energy. Thus, although pixel inten- 
sity will increase with greater number of microbubbles, the 
relation at present does not conform to any predictable 
mathematical model. The errors induced by these limitations 
are further magnified when the images are transferred into 
video format for off-line analysis. 
Number of pixels used for analysis. Because of the 
limitations mentioned, it is conceivable that the number of 
pixels used for analysis of intensity may influence the 
accuracy of the results. To our knowledge this has never 
been properly evaluated. In this investigation, the minimal 
number of pixels used for measurement of contrast intensity 
in the subendocardial and the subepicardial half of a segment 
was 63 and 86, respectively. Data analysis, however, was 
made from the average of three segments, that is, three times 
the number of pixels per segment. Other investigators 
(2554) have constructed contrast time-intensity curves from 
an equal or lesser number of pixels than ours, with favorable 
results. Furthermore, with digital coronary angiography, 
information derived from areas containing as few as three 
pixels has been found to correlate well with measurements of 
coronary flow changes (55). 
Measures to avoid variability in imaging. In this study, 
we kept gain, reject and gray scale compression constant. 
Efforts were made to obtain a consistent echocardiographic 
slice by turning off the respirator at end-inspiration. In 
addition, the transducer position was fixed and the depth 
was set at a distance of 8 cm, a point closest to the focal 
point of this transducer, where defraction of the beam is 
minimized. All injections and sonications were performed by 
the same investigator to decrease the variability in the rate of 
injection and in the number and size of the bubbles gener- 
ated. The position of the catheter was fixed externally to 
minimize its motion and reduce as much as possible the 
variability imposed by a change in position of the distal 
orifices in relation to the coronary ostia. 
Differences in slice thickness. A theoretical limitation of 
comparing contrast echocardiography with radioactive mi- 
crospheres relates to the difference in slice thickness be- 
tween the ultrasound image and the anatomic specimen; 
thus, the two techniques may not sample the identical region 
of myocardium. The thicker anatomic slice is designed to 
reduce the errors associated with the random distribution of 
microspheres (19,32,56). The benefits gained by reducing the 
variability of the technique are likely to outweigh the possi- 
bility of some variation in myocardial flow within a 1 cm slice 
of myocardium that is imaged at random by the thinner 
ultrasound plane. 
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Reproducibility of time-intensity curve measurements. 
Despite the measures taken in this study to reduce sources of 
error, the observed variability for peak intensity and area 
under the time-intensity curve ranged from 16% to 27%. 
Although the changes in contrast intensity induced by dipyr- 
idamole in the control region were well above this range, this 
degree of variability could limit the accuracy of the tech- 
nique for detecting smaller changes in myocardial flow. The 
recent availability of a new contrast agent with stable 
microbubbles of known size and concentration (57,58) may 
improve the reproducibility of measurements derived from 
the time-intensity curve. 
Conclusions. Our findings suggest that in the open chest 
dog, myocardial contrast echocardiography can be used to 
differentiate the normal increase in myocardial flow induced 
by dipyridamole from the lack of response in regions sup- 
plied by a critically stenosed artery. Furthermore, the tech- 
nique allows recognition of relative subendocardial under- 
perfusion and may therefore have important research and 
clinical applications. 
We are indebted to Almanubia Cespedes for expertise in the preparation of the 
manuscript, 
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